Global Market Access Director

Are you passionate about driving market access strategies for rare diseases? Do you have a strategic mindset and deep knowledge of health economics and payer needs? If so, we invite you to join our team as a Global Market Access Director within Rare Renal and Endocrine Disorder (RRED) at Novo Nordisk in Søborg, Denmark. 

Read more and apply today for a life-changing career.

The position is located in Søborg, Denmark.

The position
In this exciting role as Global Market Access Director within Rare Renal and Endocrine Disorder (RRED), together with your team, you will generate evidence to support the strategy in order to drive the best access for patients. 

The Global Market Access Director RRED manages the development of frameworks to be rolled out across Novo Nordisk. This requiring strategic mindset, collaboration across multiple boundaries and deep knowledge of strategic pricing, health economics, and payer needs.

Some of your responsibilities that you will find:

• Globally responsible for development and approval of Global Market Access RRED team deliverables, including the HE and pricing inputs. 
• Responsible for HE publications, posters and other activities to support the medical dialogue with payers, HCP’s and other stakeholders.
• Management of Global Market Access RRED team ensuring working environment conducive to high performance and team development. 
• Ensure successful launches of pipeline brands as well as sustaining access of in market brands.
• Lead collaboration efforts to align Global Market Access priorities and strategies with critical business functions (e.g. Global Public Affairs/Global Medical Affairs/Global Development). 

Qualifications 

• Relevant PhD/MSc in Health Economics or a related field. 
• At least 8+ years in the pharmaceutical industry working with Market Access launches, strategic pricing and/or Health Economics and Outcomes Research (HEOR) is essential.
• Demonstrate an up-to-date and advanced understanding of payer and policy-maker landscapes, HEOR and PRO (Patient Reported Outcome) at local and regional levels. 
• People management experience.
• Previous working experience within rare disease is considered an advantage.

As a person, you are skilled at building and maintaining strategic relations with both internal and external stakeholders, adept at using influence and negotiation to foster collaborative partnerships. Additionally, you excel in encouraging seamless information flow between individuals and the business, ensuring efficient communication.

Also, you are fluent in both spoken and written English.

About the Department 
Global Rare Disease Access and Pricing (GRDAP) is a department within Rare Disease Operations, the global head office of the rare disease arm of Novo Nordisk, driving change for patients in rare blood and rare endocrine disorders. Based in Søborg, Denmark, our expanding and high-performing team is responsible for optimising market access and pricing for the Rare Disease product portfolio. 

We work closely with key internal stakeholders to establish strategies and support tactics in pricing, reimbursement, health economics & outcomes research, and value communication. Our assignments are characterised by a high degree of variability and complexity, requiring independence and initiative.

Contact 
For further information, please contact Ulla Slothuus, VP Global Market Access and Pricing at +45 4444 8888.  

Deadline
Please apply before 7th November.

You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. 

To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV.

Please note that only applications in English will be considered.

Applications will be reviewed on a daily basis, so we encourage to apply as soon as possible.

Working at Novo Nordisk
Novo Nordisk is a leading global healthcare company with a 100-year legacy of driving change to defeat serious chronic diseases. Building on our strong legacy within diabetes, we are growing massively and expanding our commitment, reaching millions around the world and impacting more than 40 million patient lives daily. All of this has made us one of the 20 most valuable companies in the world by market cap. Our success relies on the joint potential and collaboration of our more than 63,000 employees around the world. 

We recognise the importance of the unique skills and perspectives our people bring to the table, and we work continuously to bring out the best in them. Working at Novo Nordisk, we're working towards something bigger than ourselves, and it's a collective effort. Join us! Together, we go further. Together, we're life changing.
 

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. 

At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.